Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to ...

Snowflake's aggressive R&D spending is expected to lead to new offerings and robust cross-selling, enhancing its bullish ...

Boston Scientific Corporation BSX, despite industrywide macroeconomic upheavals, has been seeing strong growth momentum ...

John Ransom, Raymond James, joins 'Fast Money' to talk why he is still optimistic on UnitedHealth despite DOJ probe.

Goldman Sachs analyst Will Nance maintained a Buy rating on Visa (V – Research Report) today and set a price target of $384.00. The company’s ...

These four Goldman Sachs dividend energy stock picks offer outstanding entry points and have up to 50% upside potential.

Benchmark Co. analyst David Williams maintained a Buy rating on Rigetti Computing (RGTI – Research Report) today and set a price target of ...

An analyst may even go so far as to indicate that a stock is a “strong buy.” At the same time, you may choose to swing trade the asset for a profit and come back later to start the process all ...

Another ASX 200 blue chip share that could be a top buy for an SMSF is CSL. It is the biotechnology giant behind the CSL ...

All of this means Nvidia makes a great AI stock to buy ahead of Feb. 26. If the stock rises or falls after the report, that's ...

Shares of Arista Networks ( ANET -4.93%) slipped despite the cloud computer networking switch maker reporting solid fourth ...